Cargando…
Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170215/ https://www.ncbi.nlm.nih.gov/pubmed/32188993 http://dx.doi.org/10.1210/clinem/dgaa144 |
_version_ | 1783523849572188160 |
---|---|
author | Tsang, Venessa H M McGrath, Rachel T Clifton-Bligh, Roderick J Scolyer, Richard A Jakrot, Valerie Guminski, Alexander D Long, Georgina V Menzies, Alexander M |
author_facet | Tsang, Venessa H M McGrath, Rachel T Clifton-Bligh, Roderick J Scolyer, Richard A Jakrot, Valerie Guminski, Alexander D Long, Georgina V Menzies, Alexander M |
author_sort | Tsang, Venessa H M |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7170215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-71702152020-04-24 Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes” Tsang, Venessa H M McGrath, Rachel T Clifton-Bligh, Roderick J Scolyer, Richard A Jakrot, Valerie Guminski, Alexander D Long, Georgina V Menzies, Alexander M J Clin Endocrinol Metab Online Only Articles Oxford University Press 2020-03-19 /pmc/articles/PMC7170215/ /pubmed/32188993 http://dx.doi.org/10.1210/clinem/dgaa144 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Online Only Articles Tsang, Venessa H M McGrath, Rachel T Clifton-Bligh, Roderick J Scolyer, Richard A Jakrot, Valerie Guminski, Alexander D Long, Georgina V Menzies, Alexander M Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes” |
title | Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes” |
title_full | Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes” |
title_fullStr | Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes” |
title_full_unstemmed | Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes” |
title_short | Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes” |
title_sort | response to letter to the editor: “checkpoint inhibitor-associated autoimmune diabetes is distinct from type 1 diabetes” |
topic | Online Only Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170215/ https://www.ncbi.nlm.nih.gov/pubmed/32188993 http://dx.doi.org/10.1210/clinem/dgaa144 |
work_keys_str_mv | AT tsangvenessahm responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes AT mcgrathrachelt responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes AT cliftonblighroderickj responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes AT scolyerricharda responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes AT jakrotvalerie responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes AT guminskialexanderd responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes AT longgeorginav responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes AT menziesalexanderm responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes |